Virios Therapeutics financials at a glance

+ Portfolio

The revenue of Virios Therapeutics is reported as 0 billion Dollars in the fiscal year 2023. The earnings were -0.34 Dollars per share in 2023, which was 42.19 higher than 2021. And about 0 billion Dollars are reported as free cash flow in the financials of Virios Therapeutics 2023. No dividends were paid to the shareholders of the Virios Therapeutics stock NasdaqCM:VIRI in the financial year 2023.

$0.00M

Revenue

$-1.11

Earnings Per Share

0.00%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

0.00

Earnings Per Share

-1.11

Gross Margin %

0.00

Free Cash Flow

0.00

Financials

Year	Year	TTM	2022	2021
Rev.	Revenue	N/A	$0.00M	$0.00M
GM %	Gross Margin %	0.00%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-0.34	$-1.11	$-1.92
Div.	Dividends	N/A	$0.00	$0.00
PR %	Payout Ratio %	0	0	0
Sha.	Shares	N/AM	18.33M	8.33M
OCF	Operating Cash Flow	N/A	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$-0.33	$-1.04	$-1.88

Virios Therapeutics financials at a glance

Financials

Discover